BB, I agree the PIPE and freebies are going to be around a while and we'll just have to deal with it. As the pps tracks North the occasional dips will be expected. Now, I see the two big catalysts required to seriously jolt this stagnant activity are: 1) the announcement that SCRC is cash flow positive. As you eluded to, the revenues are real and increasing every month. However, unless Mr. Schneiderman is working on expanding the number of pharmacies and staff, I see the MAP revenues maxing out between $4 and $4.5M. There are only so many scripts one pharmacy can fill in a month. But even if SCRC maintains the current revenue volume that's a $48M annual run rate. No bad at all for a little penny stock company. And I can tell you, more and more physicians and surgeons are seeing compounding as a viable option to oral meds and as a result the market will continue to grow. 2) As Celtics has stated several times, SCRC needs to demonstrate earnings.
I believe all this will happen in due time and for those of US willing to wait it out, the rewards will be incredible. As to those on the other board, most of them are self ordained experts who know absolutely nothing with one goal and selfish agenda, to scare investors into selling for their own gain.
SCRC will be around for some time to come AND SO WILL I!